DNLI Competitors & Alternatives
Compare Denali Therapeutics Inc with similar stocks in the same industry
Biotechnology
DNLI
Main Stock$26.24
Tradestie Score
59
Market Cap
$2.18B
Revenue Growth
-1.0%
Analyst Upside
+29.3%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$140.64
|
$3.98B | - | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$83.46
|
$3.92B | - | 40 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$118.89
|
$3.91B | - | 56 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$19.31
|
$3.83B | - | 58 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$18.64
|
$3.68B | - | 57 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$126.72
|
$3.67B | - | 56 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.13
|
$3.59B | 13.2 | 57 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$26.17
|
$3.58B | 11.7 | 59 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$317.44
|
$3.49B | 41.7 | 57 | Compare |
More DNLI Analysis
Data updated: Jul 07, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry